We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

77 Elektronika Highlights Latest Urinanalysis Solutions at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023
Print article
Image: The LabStrip U mALB/CREA urine test strips are in vitro medical diagnostic devices for professional use (Photo courtesy of 77 Elektronika)
Image: The LabStrip U mALB/CREA urine test strips are in vitro medical diagnostic devices for professional use (Photo courtesy of 77 Elektronika)

77 Elektronika (Budapest, Hungary) is participating at Medlab Middle East 2023 where the company is showcasing its full product range, including its latest urine test strip - the LabStrip U12 mALB/CREA - alongside the new DocUReader 2 Pro urine analyzer.

At Medlab Middle East 2023, 77 Elektronika is demonstrating the LabStrip U mALB/CREA urine test strips designed for the semi-quantitative determination of albumin and creatinine in fresh human urine and the screening of samples for microalbuminuria. LabStrip U mALB/CREA is intended to be used as a screening test for the detection of pathologies associated with kidney diseases. Each test strip contains two test zones, which incorporate sensitive chemicals. If these zones come into contact with urine, a chemical reaction takes place, which results in the discoloration of the test zone.

The urine test strips can be evaluated and read on the new DocUReader 2 Pro urine analyzer that is also on display at the show. The instrument is intended for in vitro diagnostic use by qualified physicians and laboratory staff, but does not require special training to be used. The compact design of this lightweight instrument offers the broadest features and highest flexibility available on any desktop size urine analyzer. The system offers excellent accuracy, simple operation, high flexibility and connectivity as well as enhanced security and quality control functions.

In addition, 77 Elektronika is showcasing the LabUMat 2 and Urised 3 Pro that combines chemistry and sediment analysis in one system. The LabUMat 2 is a high throughput, automated urine chemistry analyzer that can evaluate 10 chemical parameters of LabStrip U11 Plus GL test strips and three physical parameters of urine samples. The UriSed 3 is an automated urine sediment analyzer providing whole field of view microscopic images of urine sediment and detecting 16 sediment particles using Urised Cuvettes. The efficiencies of the LabUMat 2 and the UriSed 3 are maximized when these instruments are used as one system.

Related Links:
77 Elektronika 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more